or Try an Advanced Search...

    Counter Pharmaceutical Products Stocks List

    Symbol Grade Name % Change
    JNJ D Johnson & Johnson -1.82
    TARO C Taro Pharmaceutical Industries -0.14
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pharmaceutical Products Pharmacology Active Pharmaceutical Ingredients Antipsychotic Blood Glucose Monitoring Cardiovascular Disease Contact Lens Contact Lenses Diagnostic Products Dow Jones Component Drug Wholesalers Energy Products Gastrointestinal General Surgery Generic Drug Glucose Health Sciences Hematology Immunology Infection

    Related ETFs - A few ETFs which own one or more of the above listed Counter Pharmaceutical Products stocks.

    Symbol Grade Name Weight
    IHE D iShares U.S. Pharmaceutical ETF 22.5
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 6.97
    FLV A American Century Focused Large Cap Value ETF 6.89
    XLV C SPDR Select Sector Fund - Health Care 6.72
    IYH C iShares U.S. Healthcare ETF 6.64
    View all Counter Pharmaceutical Products ETFs...
    Compare ETFs
    Compare FLV to IYH Compare FLV to XLV Compare FTXH to XLV

        Counter Pharmaceutical Products Stocks Recent News

        Date Stock Title
        May 24 JNJ Johnson & Johnson (JNJ) Stock Falls Amid Market Uptick: What Investors Need to Know
        May 23 JNJ ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC
        May 23 JNJ Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
        May 23 JNJ ASCO24: An early look at cancer drug study results
        May 23 JNJ Johnson & Johnson: Vital Signs Decent, A Compelling Value Case
        May 23 TARO Taro shareholders approve go-private deal with Sun Pharma
        May 23 TARO Taro Shareholders Approve Merger with Sun Pharma
        May 23 JNJ J&J faces lawsuit over talc-related bankruptcy filings
        May 22 JNJ Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?
        May 22 JNJ Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies
        May 22 JNJ Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American
        May 22 JNJ J&J’s Tremfya superior to Stelara in Phase II/III Chron’s disease trials
        May 21 JNJ Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Johnson & Johnson Stock
        May 21 JNJ J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
        May 20 TARO Taro Pharmaceutical GAAP EPS of $0.40 beats by $0.09, revenue of $164.94M beats by $8.88M
        May 20 TARO Taro Provides Results for Year Ended March 31, 2024
        May 20 JNJ Johnson & Johnson's Tremfya meets goals in late-stage trial for ulcerative colitis
        May 20 JNJ Pulsed field ablation poised for fast adoption, analysts say
        May 20 JNJ J&J posts latest Varipulse data while awaiting FDA review
        May 19 JNJ Biopharma M&A surges year over year in Q1
        Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Pharmaceutical Products Pharmacology Active Pharmaceutical Ingredients Antipsychotic Blood Glucose Monitoring Cardiovascular Disease Contact Lens Contact Lenses Diagnostic Products Dow Jones Component Drug Wholesalers Energy Products Gastrointestinal General Surgery Generic Drug Glucose Health Sciences Hematology Immunology Infection
        Counter Pharmaceutical Products

        Counter Pharmaceutical Products are products that are designed to help people reduce their risk of developing certain diseases or illnesses. These products may include vitamins, minerals, herbal supplements, and other natural remedies. They are often used to treat conditions such as high cholesterol, high blood pressure, diabetes, and obesity.

        Browse All Tags